Modern Management of Advanced Pancreatic Cancer: Expert Guidance on Clinical Challenges

Gain expert guidance on the latest treatment of newly diagnosed and relapsed/refractory advanced pancreatic cancer with this CME-certified on-demand Webcast, downloadable slideset, and 2 FAQ modules.
Tanios Bekaii-Saab
Tanios Bekaii-Saab, MD, FACP
Program Director
Andrew H. Ko, MD
Program Director
Tanios Bekaii-Saab
Tanios Bekaii-Saab, MD, FACP
Milind Javle, MD
Andrew H. Ko, MD
Dan Laheru, MD
Kenneth Yu, MD, MSc

Module

Expert answers to frequently asked questions about modern clinical management of pancreatic cancer, including diagnosis, screening, selecting chemotherapeutic agents, switching treatment, radiation, and surgery.

Tanios Bekaii-Saab Tanios Bekaii-Saab, MD, FACP
Program Director
Andrew H. Ko, MD
Program Director
Tanios Bekaii-Saab Tanios Bekaii-Saab, MD, FACP Andrew H. Ko, MD
Released: September 7, 2017

Expert answers to frequently asked questions about modern clinical management of pancreatic cancer, including diagnosis and screening, neoadjuvant treatment, first-line and second-line therapy, and novel approaches such as combining immunotherapy with chemotherapy or radiation.

Tanios Bekaii-Saab Tanios Bekaii-Saab, MD, FACP
Program Director
Andrew H. Ko, MD
Program Director
Tanios Bekaii-Saab Tanios Bekaii-Saab, MD, FACP Milind Javle, MD Andrew H. Ko, MD Dan Laheru, MD Kenneth Yu, MD, MSc
Released: January 2, 2018
Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
PIM Logo

Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112

Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)
ahughes@pimed.com
www.pimed.com

Supported by educational grants from
Celgene Corporation
Halozyme Therapeutics
Merrimack Pharmaceuticals

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue